| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $672K | -68.1% |
| Cost of Revenue | $1.7M | -80.5% |
| Gross Profit | -$1.0M | +84.4% |
| R&D Expense | $82.2M | -25.5% |
| SG&A Expense | $42.6M | +1.5% |
| Operating Income | -$137.4M | +13.6% |
| Income Tax | $0 | — |
| Net Income | -$123.5M | +19.5% |
| EPS (Basic) | -$0.68 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.9M | -89.2% |
| Short-term Investments | $150.3M | -22.4% |
| Accounts Receivable | $40K | -96.5% |
| Inventory | $0 | -100.0% |
| Current Assets | $181.7M | -44.0% |
| Total Assets | $328.4M | -26.5% |
| Current Liabilities | $15.1M | +3.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$117.0M | -0.1% |
| Capital Expenditures | $7.4M | +156.5% |
| Investing Cash Flow | $18.3M | +183.1% |
| Financing Cash Flow | -$15K | +80.8% |
| Free Cash Flow | -$124.4M | -3.8% |
| +21.8% |
| EPS (Diluted) | -$0.68 | +21.8% |
| Total Liabilities |
| $22.1M |
| -4.5% |
| Stockholders' Equity | $306.3M | -27.7% |